We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA has enrolled four devices in its Total Product Life Cycle Advisory Program (TAP) pilot, which is designed to give faster, more widespread access to medical devices of public health importance and strengthen the agency’s Breakthrough Devices program.